Modern Optometry - MOD

01/16/2026

Read this article to gain insights about Demodex blepharitis from Dr. Ravi Patel. Learn more about pivotal SATURN data and the ERSA and RHEA pilot studies.

See here: https://ow.ly/nlzg50XWSmi

01/13/2026

When it comes to children’s myopia management, it’s important to look beyond correction alone. Essilor® Stellest® lenses are clinically proven to slow myopia progression in children*¹. Set your practice apart with the first and only FDA market authorized spectacle lens for myopia control in children*¹.​

Discover more here: https://ow.ly/nkqB50XU8hu
​
*Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.​
1.Essilor International, data on file (2025)

Stellest® lenses are Essilor®’s latest innovation to slow down myopia progression in children. Essilor® Stellest® lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day3

01/11/2026

How can optometrists balance efficiency, innovation, and patient connection? In this special MOD Pod installment, Dr. Jacob Lang leads a discussion with Dr. Diana Chu and Dr. Jason Compton on building sustainable, forward-thinking practices.

Listen here: https://ow.ly/cvmz50XQmMu

01/08/2026

Stay informed about approved, investigational, and emerging glaucoma treatments your patients may ask about with the Glaucoma Pipeline 2026 poster.

Learn More: https://ow.ly/JF8h50XQmxc

12/29/2025

A 46-year-old man presented for a second opinion from an outside eye doctor for a possible hereditary retinal dystrophy. The patient reported having difficulty seeing for years but could not specify when his poor distance and near visual acuity became truly bothersome.

He described looking to the side of central areas of blindness to perceive the details of an object of interest. Upon questioning, the patient said his vision was poor under all circumstances, rather than worse during the day (ie, hemeralopia) or at night (ie, nyctalopia).

His medical history was otherwise unremarkable, and he was not taking any medications. Continue reading the full article from Chris Borgman, OD, FAAO and Peter Anderton, OD here: https://ow.ly/8N1z50XQa43

12/23/2025

[TO THE POINT] Dr. Tracy Doll sits down with Drs. Jackie Garlich and Jessilin Quint to discuss beauty and aesthetics considerations for supporting a healthy ocular surface.

Listen here: https://ow.ly/B0ee50XMMRl

12/22/2025

Efficiency isn’t about speed—it’s about clarity and collaboration. In the final EMPOWER Series installment for the 2025 season, Dr. Jacob Lang hosts Dr. Diana Chu and Dr. Jason Compton to explore systems that streamline care and strengthen practice sustainability.

Read now: https://ow.ly/mzou50XMIpb

12/18/2025

When it comes to children’s myopia management, it’s important to look beyond correction alone.​
​
Essilor® Stellest® lenses slowed myopia progression by 71% on average over a 2-year period.*¹​
​
Bring trusted, science-backed innovation into your practice by choosing Essilor® Stellest® lenses.​
​
Learn more here: https://ow.ly/k5Og50XLJRC
​
**Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.​
1Essilor International, data on file (2025)​

12/12/2025

Dr. Jason Besecker joins To the Point co-hosts Drs. Jackie Garlich and Jessilin Quint to share his experience with starting a dry eye only practice after years of working in an OD/MD clinic.

Listen here: https://ow.ly/9J6R50XBtGT

12/11/2025

UGH Syndrome isn’t just rare—it’s easy to miss. A reminder that implant positioning and postoperative vigilance remain key to protecting vision.

Read the full case from Jacob Lang, OD, FAAO here: https://ow.ly/OH0450XHPKT

12/10/2025

In this episode of the MOD Pod, Dr. Koetting sits down with Drs. Pelino and Runyon to discuss metabolic syndrome and the changing landscape of geographic atrophy management.

Listen in here: https://ow.ly/cQcc50XH69X

12/02/2025

In this episode of The MOD Pod, host Cecelia Koetting, OD, FAAO, Dipl ABO, sits down with Jill Gottehrer, OD, and Steven Ferrucci, OD, FAAO, to discuss comanaging patients with age-related macular degeneration and the latest tools changing the treatment paradigm, such as home monitoring and photobiomodulation.

Listen more here: https://ow.ly/Nzmm50Xyml7